The Science and Medical Advisory Team at Canget BioTekpharma plays a crucial role in guiding the development of innovative cancer-targeting therapies. Comprising experts in drug consulting and scientific research, the team advises on clinical trial designs, ensures compliance with regulatory standards, and provides insights on emerging scientific trends to optimize the efficacy and safety of anticancer agents. Their expertise helps bridge the gap between cutting-edge research and practical medical applications, contributing to the advancement of cancer treatment.
Alex A. Adjei
Chief Medical Officer
Carl Porter
Scientific Advisor
Fengzhi Li
Chief Scientific Officer
Geoffrey White
Drug Consulting Officer
Gerald Fetterly, Jr.
Scientific Advisor
Lili Tian
Scientific Advisor
Nathan R. Wall
Scientific Advisor
Ravindra K Pandey
Scientific Advisor
Youcef M. Rustum
Scientific Advisor
View all